Founders Research Corporation

Philadelphia, Pennsylvania 19152

0 studies enrolling now · 9 studies all time

What they study most

Arthritis, Arthritis, Rheumatoid, Chronic Disease, Chronic Low Back Pain, Chronic Nonmalignant and Nonneuropathic Pain, Chronic Pain, Diarrhea-predominant Irritable Bowel Syndrome, Drug Abuse, Narcotic Abuse, Opiate Addiction, Opioid-Related Disorders, Osteoarthritis

Studies at this site

• Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D) — Completed
• Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study — Stopped early
• Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen — Completed
• Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement — Completed
• Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. — Completed
• Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• Long Term Safety and Efficacy Study of Tanezumab in Subjects With Osteoarthritis of the Hip or Knee — Completed
• Discontinuation vs Continuation of Long-term Opioid Therapy in Suboptimal and Optimal Responders With Chronic Pain — Stopped early
• Conversion to Embeda With Rescue Trial — Stopped early